DTXClass II
Gas Control Unit, Cardiopulmonary Bypass
21 CFR 870.4300 / Cardiovascular
DTX is the FDA product code for Gas Control Unit, Cardiopulmonary Bypass, a class II device type, regulated under 21 CFR 870.4300. As of , FDA records hold 10 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- DTX
- Device name
- Gas Control Unit, Cardiopulmonary Bypass
- Regulation
- 21 CFR 870.4300
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- Yes
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 10
- Ingested recalls
- 0
Clearances, product code DTX
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1979 | 2 |
| 1982 | 1 |
| 1986 | 1 |
| 1997 | 1 |
| 2003 | 1 |
| 2010 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Applicants with the most clearances
Product code DTX| Applicant | Clearances |
|---|---|
| Spectrum Medical Inc | 3 |
| 3M Health Care, Sarns | 1 |
| Cobe Laboratories, Inc. | 1 |
| Coeur Laboratories, Inc. | 1 |
| Cordis US Corp. | 1 |
| Gambro, Inc. | 1 |
| Sechrist Industries Inc | 1 |
| LivaNova Deutschland GmbH | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
